Question follow-through · 62274
Drugs: Misuse
To ask the Secretary of State for Health and Social Care, what information his Department holds on the impact of (a) diamorphine assisted therapy, (b) safe consumption rooms and (c) needle and syringe exchange services on rates of skin and soft tissue inf
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 24 Jun 2025
- Target answer date
- 26 Jun 2025
- Answer
- 8 Jul 2025 · 14 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Measles: Vaccination · 8 Jul 2025
- Vaccine Damage Payment Scheme · 10 Jul 2025
- Vaccine Damage Payment Scheme · 10 Jul 2025
- Vaccine Damage Payment Scheme · 10 Jul 2025
- Drugs: Misuse · 18 Jul 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
24 Jun 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what information his Department holds on the impact of (a) diamorphine assisted therapy, (b) safe consumption rooms and (c) needle and syringe exchange services on rates of skin and soft tissue inf
26 Jun 2025
Target answer date
Date supplied by the official written-questions record.
8 Jul 2025
Answer published
The Department does not collect information on the impact of diamorphine assisted therapy (DAT), safe consumption rooms and needle and exchange services on rates of soft skin tissue infections (SSTI). The Department is aware of the dangers of SSTI to peop...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Measles: Vaccination
8 Jul 2025 · To ask the Secretary of State for Health and Social Care, what steps he plans to take to increase the uptake of measles vaccines.
Vaccine Damage Payment Scheme
10 Jul 2025 · To ask the Secretary of State for Health and Social Care, how many applications have been made to the vaccine damage payment scheme since 2020, by vaccine type.
Vaccine Damage Payment Scheme
10 Jul 2025 · To ask the Secretary of State for Health and Social Care, what proportion of applications to the vaccine damage payment scheme since 2020 have been successful, by vaccine type.
Vaccine Damage Payment Scheme
10 Jul 2025 · To ask the Secretary of State for Health and Social Care, what proportion of applications to the vaccine damage payment scheme since 2020 have been successful on appeal,by vaccine type.
Drugs: Misuse
18 Jul 2025 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the potential impact of (a) diamorphine assisted therapy, (b) safe consumption rooms and (c) other drug harm reduction services on the level of ambulance ca
Opioids
21 Jul 2025 · To ask the Secretary of State for Health and Social Care, what steps he has taken to integrate synthetic opioid awareness into local authorities’ Drug Strategies since 5 July 2025; and how much of the 2025/26 targeted drug, alcohol treatment and recovery
Opioids: Health Education
21 Jul 2025 · To ask the Secretary of State for Health and Social Care, what steps he has taken to raise awareness among (a) people sleeping rough, (b) socially isolated people and (c) other at-risk populations on the dangers of synthetic opioids since 2024.
Opioids: Health Education
21 Jul 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of local Combating Drugs Partnerships in raising awareness of (a) synthetic opioids and (b) how to respond when witnessing an opioid overdose; and w
Kava-Kava in Food (England) Regulations 2002
4 Sept 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has made a recent assessment of the adequacy of controls on the (a) sale and (b) import of kava for food purposes in The Kava-kava in Food (England) Regulations 2002.
Kava-Kava in Food (England) Regulations 2002
4 Sept 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of new research into the hepatotoxicity risk posed by kava on The Kava-kava in Food (England) Regulations 2002.
Kava-Kava in Food (England) Regulations 2002
4 Sept 2025 · To ask the Secretary of State for Health and Social Care, with reference to the Kava-kava in Food (England) Regulations 2002, what provision exists for the revocation of this legislation should the evidence no longer support such controls.
Obesity: Prescription Drugs
30 Oct 2025 · To ask the Secretary of State for Health and Social Care, if he will make it his policy that weight loss injections can only be prescribed following a face-to-face meeting with a GP who can determine that the patient (a) does not have too low a BMI and (b